Mo1892 – Non-Medical Reverse Switch Between the Originator Infliximab and Its Biosimilar in Patients with Inflammatory Bowel Disease: Clinical Outcomes and Therapeutic Drug Monitoring
2019; Elsevier BV; Volume: 156; Issue: 6 Linguagem: Inglês
10.1016/s0016-5085(19)39159-0
ISSN1528-0012
AutoresLóránt Gönczi, Ákos Iliás, K Szántó, Zsuzsanna Kürti, Petra A. Golovics, Klaudia Farkas, Eszter Schäfer, Zoltán Szepes, Balázs Szalay, Áron Vincze, T Szamosi, Tamás Molnár, Péter L. Lakatos,
Tópico(s)Microscopic Colitis
Referência(s)